Why the study?
Does low molecular weight heparin reduce deep-vein thrombosis compared to unfractionated heparin and warfarin in patients undergoing orthopaedic surgery?
Does low molecular weight heparin reduce deep-vein thrombosis compared to unfractionated heparin and warfarin in patients undergoing orthopaedic surgery?
In orthopaedic surgery, LMWH is superior to both UFH and warfarin for DVT prevention, with a minor bleeding risk that is lower than UFH but higher than warfarin.
Answers are grounded in this paper and cite their sources.
LMWH preferred for DVT prophylaxis in orthopaedic surgery; confirms Level 1 superiority versus UFH and warfarin.
UNLABELLED: The efficacy and safety of low molecular weight heparin (LMWH), unfractionated heparin (UFH) and warfarin for prophylaxis of thrombo-embolism in orthopaedic surgery were compared using meta-analysis techniques. Twenty-two studies were included, 2 of which compared LMWH to warfarin. The mean probabilities to develop deep-vein thrombosis (DVT), pulmonary embolism and major and minor bleeding using UFH were: 0.21 (95% confidence interval, CI: 0.18-0.24); 0.01 (95% CI: 0.01-0.02); 0.05 (95% CI: 0.03-0.07), and 0.19 (95% CI: 0.17-0.22), respectively. The relative risk (RR) of DVT for LMWH vs. UFH was 0.76 (95% CI: 0.60-0.91), p < 0.05 and for LMWH vs. warfarin 0.78 (95% CI: 0.69-0.87), p < 0.05. The RR of minor bleeding for LMWH vs. UFH was 0.76 (95% CI: 0.64-0.92), p < 0.05. The RR of minor bleeding for LMWH vs. warfarin was 3.28 (95% CI: 2.21-4.70), p < 0.05. CONCLUSION: in orthopaedic surgery, LMWH is significantly superior to both UFH and warfarin in the prevention of DVT and results in significantly less minor bleeding complications when compared to UFH, but significantly more minor bleeding when compared to warfarin.
No takes yet. Share an insight, caveat, or question.
Palmer et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: